| Literature DB >> 27716316 |
Matteo Piga1,2, Luca Saba3, Alessandra Gabba4, Mattia Congia4, Antonella Balestrieri3, Alessandro Mathieu4, Alberto Cauli4.
Abstract
BACKGROUND: The aim was to determine the accuracy of high-resolution ultrasonography (US) for detecting erosion in the metacarpophalangeal (MCP) and wrist joints of patients with different subtypes of systemic lupus erythematosus (SLE) arthritis, using computed tomography (CT) as the gold-standard reference method.Entities:
Keywords: Arthritis; Computed tomography; Erosion; Jaccoud’s arthropathy; Rhupus; Systemic lupus erythematosus; Ultrasound
Mesh:
Year: 2016 PMID: 27716316 PMCID: PMC5050586 DOI: 10.1186/s13075-016-1125-8
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Baseline demographic data and cumulative clinical and serological data of the study cohort
| SLE (n = 26) | Rhupus syndrome (n = 9) | Jaccoud’s arthropathy (n = 10) | NDNE (n = 7) | |
|---|---|---|---|---|
| Age (mean ± SD) | 49.4 ± 16.0 | 41.1 ± 5.7 | 61.3 ± 14.3 | 43.1 ± 16.5 |
| Disease duration (mean ± SD) | 15.6 ± 8.2 | 13.7 ± 6.7 | 21.7 ± 8.5 | 10.8 ± 4.5 |
| Gender, female, | 26 | 9 | 10 | 7 |
| Cumulative 1997 ACR criteria | ||||
| Malar rash | 12 (46.2) | 5 (55.5) | 4 (40.0) | 3 (42.8) |
| Discoid rash | 2 (7.7) | 0 | 1 (10.0) | 1 (14.3) |
| Photosensitivity | 4 (15.4) | 1 (11.1) | 2 (20.0) | 1 (14.3) |
| Oral/nasopharyngeal ulcers | 2 (7.7) | 0 | 1 (10.0) | 1 (14.3) |
| Serositis | 15 (57.7) | 4 (44.4) | 8 (80.0) | 3 (42.8) |
| Renal disorders | 5 (19.2) | 0 | 2 (20.0) | 3 (42.8) |
| Neurologic disorders | 2 (7.7) | 0 | 2 (20.0) | 0 |
| Hematological disorders | 14 (53.8) | 5 (55.5) | 7 (70.0) | 2 (28.6) |
| ANA | 26 (100) | 9 (100) | 10 (100) | 7 (100) |
| Anti-dsDNA | 18 (69.2) | 6 (66.7) | 8 (80.0) | 4 (57.1) |
| Antiphospholipid antibodies | 7 (26.9) | 3 (33.3) | 3 (30.0) | 1 (14.3) |
| Other laboratory findings | ||||
| Anti-Ro/SSA | 14 (53.8) | 4 (44.4) | 5 (50.0) | 5 (71.4) |
| Anti-La/SSB | 2 (7.7) | 0 | 1 (10.0) | 1 (14.3) |
| Anti-RNP | 2 (7.7) | 0 | 0 | 2 (28.6) |
| Anti-Sm | 2 (7.7) | 0 | 0 | 2 (28.6) |
| Rheumatoid factor | 11 (37.9) | 7 (77.8) | 1 (10.0) | 3 (42.8) |
| Anti-CCP | 7 (26.9) | 6 (66.7) | 0 | 1 (14.3) |
| SLICC/damage index (mean ± SD) | 1.4 ± 1.3 | 1.4 ± 0.5 | 2.6 ± 1.3 | 0.6 ± 0.5 |
| Medication receiveda | ||||
| Total corticosteroid dose >50 g | 15 (57.7) | 3 (33.3) | 10 (100) | 2 (28.6) |
| Antimalarial agents | 25 (96.1) | 8 (88.9) | 10 (100) | 7 (100) |
| Methotrexate | 20 (76.9) | 9 (100) | 6 (60.0) | 5 (71.4) |
| Azathioptine | 7 (26.9) | 1 (11.1) | 4 (40.0) | 2 (28.6) |
| Micophenolate | 4 (15.4) | 1 (11.1) | 1 (10.0) | 2 (28.6) |
| Rituximab | 8 (30.7) | 4 (44.4) | 2 (20.0) | 2 (28.6) |
| Belimumab | 1 (3.8) | 0 | 0 | 1 (14.3) |
| Anti TNF-alpha | 3 (11.5) | 3(33.3) | 0 | 0 |
| Anti IL-6 | 2 (7.7) | 1 (11.1) | 1 (10.0) | 0 |
Unless otherwise specified, values are the number of patients (values in brackets are percentage). aIncludes medication ongoing at enrollment and past treatment. Antiphospholipid antibodies included lupus anticoagulant, anticardiolipin antibodies IgG and IgM, beta2-glicoproteinI IgG and IgM. Anti-extractable nuclear antigens (SSA, SSB, Sm, RNP, Rheumatoid factor and anti-cyclic citrullinated peptide antibodies (antiCCP) were tested by ELISA. Antinuclear antibodies (ANA) were tested by IIF, using Hep2 cell substrate; positivity was defined as a titer ≥1:320. Anti-double-stranded DNA (Anti-dsDNA) antibodies were tested by Farr assay. SLE systemic lupus erythematosus, NDNE non-deforming non-erosive, ACR American College of Rheumatology, SLICC Systemic Lupus International Collaboration Clinics
Distribution of erosions in different region of interest according to CT and US, and sensitivity, specificity, accuracy and k values for high-resolution US in detecting erosion (grading from 0 to 3) at different joint sites using CT as the reference method
| Quadrants | CT-detected erosions | US-detected erosions | Sensitivity (%) | Specificity (%) | Exact agreement (%) | k values (95 % CI) | |
|---|---|---|---|---|---|---|---|
| Second metacarpal head | 156 | 27 (17.3) | 21 (13.5) | 51.9 | 95.3 | 87.8 | 0.63 (0.43 to 0.83) |
| Dorsal | 52 | 16 (30.8) | 13 (25.0) | 56.3 | 88.9 | 78.8 | 0.51 (0.26 to 0.75) |
| Lateral | 52 | 11 (21.2) | 8 (15.4) | 54.5 | 95.1 | 86.5 | 0.77 (0.54 to 1.00) |
| Volar | 52 | 0 | 0 | NC | NC | NC | NC |
| Third metacarpal head | 104 | 15 (14.4) | 4 (3.8) | 20.0 | 98.9 | 87.5 | 0.26 (0.03 to 0.48) |
| Dorsal | 52 | 14 (21.2) | 4 (15.4) | 21.4 | 97.4 | 76.9 | 0.24 (0.02 to 0.46) |
| Volar | 52 | 1 (1.9) | 0 | 0 | 100 | 98.1 | 0 (0.00 to 0.00) |
| Fourth metacarpal head | 104 | 7 (6.7) | 1 (0.9) | 14.3 | 100 | 94.2 | 0.19 (-0.12 to 0.51) |
| Dorsal | 52 | 6 (11.5) | 1 (1.9) | 17.0 | 100 | 90.4 | 0.08 (-0.09 to 0.26) |
| Volar | 52 | 1 (1.9) | 0 | 0 | 100 | 98.1 | 0 (0.00 to 0.00) |
| Fifth metacarpal head | 156 | 8 (5.1) | 6 (3.8) | 50.0 | 100 | 96.3 | 0.77 (0.66 to 0.89) |
| Dorsal | 52 | 6 (11.5) | 4 (7.7) | 66.7 | 100 | 96.2 | 0.73 (0.56 to 0.90) |
| Lateral | 52 | 2 (3.8) | 2 (3.8) | 100 | 100 | 100 | 0.85 (0.74 to 0.97) |
| Volar | 52 | 0 | 0 | NC | NC | NC | NC |
| Radiocarpal | 104 | 18 (17.3) | 6 (5.8) | 33.0 | 100 | 88.5 | 0.57 (0.30 to 0.83) |
| Dorsal | 52 | 15 (28.8) | 4 (7.7) | 26.7 | 100 | 78.8 | 0.48 (0.16 to 0.80) |
| Lateral | 52 | 3 (5.7) | 2 (3.8) | 66.7 | 100 | 98.1 | 0.79 (0.39 to 1.0) |
| Ulnar head | 104 | 17 (16.3) | 5 (4.8) | 23.5 | 98.9 | 86.5 | 0.29 (0.05 to 0.54) |
| Dorsal | 52 | 13 (25.0) | 4 (7.7) | 23.1 | 97.4 | 78.8 | 0.23 (-0.03 to 0.50) |
| Lateral | 52 | 4 (7.7) | 1 (1.9) | 25.0 | 100 | 94.2 | 0.38 (-0.15 to 0.91) |
| Total | 728 | 92 (12.6) | 43 (5.9) | 35.9 | 98.7 | 90.8 | 0.50 (0.36 to 0.63) |
Unless otherwise specified, values are the number of patients (values in brackets are percentage). CT computed tomography, US ultrasound, NC not computable
Erosions detected by CT in joint quadrants and semi-quantitatively assessed according to the RAMRIS erosion score, and proportion of erosions detected by US
| RAMRIS erosion score | Quadrants with CT erosion ( | US-detected erosions (%) |
|---|---|---|
| All areas | ||
| Grade 1 (1–10 %) | 51 | 27.5 |
| Grade 2 (11 − 20 %) | 31 | 41.9 |
| Grade 3 − 10 (21–100 %) | 10 | 90.0a |
| Areas with best US reliabilityb | ||
| Grade 1 (1 − 10 %) | 15 | 53.3 |
| Grade 2 (11 − 20 %) | 15 | 60.0 |
| Grade 3 − 10 (21 − 100 %) | 5 | 100.0 |
aOnly one large computed tomography (CT)-detected erosion (grade 3) at the third metacarpophalangeal join (MCP) was not identified by ultrasound (US) because the cortical break was not accessible to US. bSecond MCP and fifth MCP quadrants. RAMRIS rheumatoid arthritis magnetic resonance imaging score
Main characteristics and distribution of US and CT abnormalities in patients with different subtypes of SLE arthropathy
| Rhupus (n = 9) | JA (n = 10) | NDNE (n = 7) | Rhupus vs JA ( | Rhupus vs NDNE ( | JA vs NDNE ( | |
|---|---|---|---|---|---|---|
| Age, years (mean ± SD) | 41.0 ± 5.7 | 61.3 ± 14.3 | 43.1 ± 16.4 |
| 0.765 |
|
| Disease duration, years (mean ± SD) | 13.7 ± 6.6 | 21.7 ± 10.7 | 10.8 ± 4.1 |
| 0.298 |
|
| Rheumatoid factor | 7 (77.8 %) | 2 (20.0 %) | 2 (28.5 %) |
|
| - |
| Anti-CCP | 6 (66.7 %) | 0 (0) | 1 (14.2 %) |
|
| - |
| US erosion number (median (25th to 75th percentile)) | 3.0 (1.7–4.2) | 0.5 (0–2.0) | 0 (0–1.0) |
|
| 0.569 |
| US quadrants with erosion | 27 (10.7 %) | 12 (4.3 %) | 4 (2.0 %) |
|
| - |
| ScUSSe total (median (25th to 75th percentile)) | 4.0 (2.5–6.0) | 1.0 (0–3.0) | 0 (0–1.0) |
|
| 0.535 |
| Grade 1 (<2 mm) | 16a | 10a | 4a |
|
|
|
| Grade 2 (2–3 mm) | 9a | 1a | 0a |
|
|
|
| Grade 3 (>3 mm) | 2a | 1a | 0a |
|
|
|
| CT erosion number (mean ± SD) | 14.0 ± 9.7 | 5.7 ± 5.1 | 4.7 ± 4.5 |
|
| 0.543 |
| RAMRIS (mean ± SD) | 21.6 ± 18.2 | 7.4 ± 7.0 | 5.1 ± 5.0 | 0.053 |
| 0.448 |
| RAMRIS MCP (median (25th to 75th percentile)) | 6.0 (4.5–10.2) | 1.0 (0–2.0) | 0 (0–1.5) |
|
| 0.353 |
| RAMRIS wrist (median (25th to 75th percentile)) | 8.0 (10.2–16.2) | 3.5 (0–11.0) | 3.0 (0.5–6.7) | 0.111 | 0.057 | 0.694 |
| Grade 1 (1–10 %) | 24a | 21a | 6a |
|
|
|
| Grade 2 (11–20 %) | 19a | 6a | 6a |
|
|
|
| Grade 3 − 10 (21–100 %) | 7a | 1a | 2a |
|
|
|
Numbers in bold indicate statistical significance for p <0.05. Boxes are empty where statistics was not applied
aAbsolute numbers referring to joint quadrants. JA Jaccoud’s arthropathy, NDNE non-deforming non-erosive, Anti-CCP anti-cyclic citrullinated peptide, US ultrasound, ScUSSe scoring ultrasound structural erosion, CT computed tomography, RAMRIS rheumatoid arthritis magnetic resonance imaging score, MCP metacarpophalangeal joint
Fig. 1Bone erosions in a patient with rhupus syndrome. Longitudinal ultrasound image of the second metacarpophalangeal joint lateral area showing a grade-2 scoring ultrasound structural erosion (arrow) with sharp margins (a) corresponding to a grade-2 rheumatoid arthritis magnetic resonance imaging score erosion (arrow) visible in the computed tomography coronal scan of the hand (b). MH second metacarpal head, PP second proximal phalanx
Fig. 2Bone erosions in patients with Jaccoud’s arthropathy. Longitudinal ultrasound (US) image of the lateral ulnar head area (U) showing a grade-2 scoring ultrasound structural erosion (ScUSSe) (arrow) with a hook-shaped deformity (arrow head) (a). U ulnae, R radial, *extensor carpi ulnaris tendon. Coronal computed tomography (CT) scan of the wrist showing a grade-4 rheumatoid arthritis magnetic resonance imaging score (RAMRIS) erosion (arrow) confirming the hook-shaped deformity (arrow head) with a bony sclerotic margin (b). Transversal US view of the second metacarpophalangeal (MCP) dorsal area showing a grade-3 ScUSSe hook-shaped (arrow head) erosion (arrow) (c) corresponding to a grade 3 RAMRIS score erosion (arrow) with hook-shaped deformity (arrow head) visible in the CT coronal scan of the hand (d). MH second metacarpal head